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We observed nonenzymic peaks when serum isoenzymes of lactate dehydrogenase (EC 1.1.1.27; LD) and creatine kinase (EC 2.7.3.2; CK) were separated by "high-performance" liquid chromatography and detected by continuously monitoring the column effluent for enzyme activity. Such background peaks were particularly apparent in CK isoenzyme profiles obtained from human sera. We observed two nonenzymic peaks with fluorescence detection, one in the CK-MB region, the other in the CK-BB region. Serum albumin was a major component in the artifactual CK-MB peak, with lipoprotein as a minor component. We present evidence that the material responsible for the other peak fluoresced quite strongly and is mostly pre-albumin. have not yet been completely identified and further elucidation is needed. An "albumin-like" artifact with an electrophoretic mobility that may be similar to that of CK-BB, depending on the medium, has been reported (5, 6). There are preliminary indications that this is an albumin complex (7), and bilirubin (8) has been tentatively identified as the partner in the complex. Early reports focused on the presence of a nonenzymic artifact in the CK-BB region (3, 4, 9), but a second, more cathodic artifact was described later (10). Figure 1 
Materials and Methods

Apparatus
Reagents
Two buffers were used for gradient elution. The "weak" buffer was 20 mmol/L tris(hydroxymethyl)aminomethane, adjusted to pH 7.8 (buffer A); the "strong" buffer contained 0.30 mol of sodium chloride per liter of buffer A.
Prepare the post-column CK assay reagent from a CPK-10 reagent kit (Biodynamics, Indianapolis, IN 46250). Combine four such vials after reconstituting each with 50 mL of the CK buffer (per liter, 400 mmol of triethanolamine, The CK isoenzyme control was obtained from Sigma (cat. no. C0300). Frozen serum samples were obtained from the University of South Alabama Medical Center. Sera from a healthy 30-year-old man were also used and assayed on the same days collected. glycol (Mr 6000) in distilled water. Vortex-mix the samples and centrifuge at 2100 X g for 1 h.
Chromatography.
Chromatograph serum samples with a linear gradient progressing from 50 to 1000 mL of strong buffer per liter in 24 mm. Separate serum proteins and CK isoenzymes with the chromatographic column (D in Figure  1 ). To detect CK isoenzymes, combine the separated isoenzymes with CK reagent (F), monitoring the NADPH produced before and after the incubation coil (I). Measure both absorbance (J1, J2) and fluorescence (K1, K2). (We included the pre-incubation coil (H) to allow the CK reaction to pass through the lag phase.) Determine CK activity by subtracting the peak areas recorded at the first detector (J1 or K1) from those at the second (J2 or K2).
To obtain serum protein profiles, substitute buffer A for the CK reagent, then record the background absorbance profile of serum proteins at 280 nm. We used the profiles recorded at the first absorbance or fluorescence detector because they exhibited better resolution. Replacing the CK reagent with buffer A also did not produce background fluorescence peaks. Figure 3 shows the fluorescence profiles of CK isoenzymes in a serum sample from a patient who had recently suffered a myocardial infarction. Subtracting the two fluorescence profiles revealed about 120 U/L CK-MM activity and about 15 U/L CK-MB activity. Subtraction also revealed the presence of a background fluorescence peak on the front of the CK-MB peak in the 8-to 10-mm region and one after CK-MB in the 12-to 14-mm region. Replacing the CK reagent with buffer A eliminated the activity peaks but not the background peaks.
Absorbance (340 nm) profiles of CK activity, obtained simultaneously with the fluorescence data shown in Figure 3 , revealed comparable amounts of CK-MM and CK-MB activity (Figure 4) . However, the background peak just before CK-MB appears much larger, and that after CK-MB much smaller, than observed in the fluorescence data. These background peaks also remained when buffer A was substituted for CK reagent. Figure 5 (Trace A) shows the background fluorescence profile of a serum sample. The background profile was similar to that found with other serum samples when the CK reagent was replaced with buffer A. The first background peak, in the 4-to 6-mm region, consistently appears when more than 100 tL of serum are applied to the column; that peak is likely caused by column overloading.
Trace B in Figure 5 demonstrates the effect of dialysis on the background fluorescence profile. Dialysis decreased the area of the background peaks in the 8-to 10-and 12-to 14-mm regions by less than 30%; Trace A, shows the immunoglobulmns first, followed by poorly resolved lipoproteins that overlap with the albumin peak, which is, as expected, the largest peak. The shoulder peak at about 12 mm is probably pre-albumin, the portion of serum proteins that migrates ahead of albumin during electrophoresis (21). Comparing this profile with the fluorescence profile, Trace B, reveals that the background peak in the 8-to 10-mm region is probably albumin.
The background fluorescence peak in the 12-to 14-mm region corresponds to the small peak appearing after albumin, tentatively identified as pre-albumm. The absence of a peak in the 4-to 6-mm region in Trace B was attributable to the use of a smaller injection volume, 102.8 L instead of 216.7 1zL. The antiserum was specific for human pre-albumin.
The conspicuous absence of a background peak in the 12-to 14-mm region in Trace A but not Trace B strongly suggests that this protein is pre-albumin. 
Discussion
